Maxim Biomedical, Inc. Announces New Minority Investment Partner and Appoints Jonathan Maa as CEO
Strategic Investment and Leadership Transition Set to Further Propel MaximBio’s Growth ROCKVILLE, Md., July 29, 2024 /PRNewswire/ — Maxim Biomedical, Inc., one of the nation’s leading end-to-end rapid diagnostic test developers and manufacturers, has received a new minority investment from CTM Investments. CTM Investments is a growth equity vehicle led by Jason Gray focused on … Read more
